Jeffrey A. Newman
Robert F. Kennedy Jr. will divest investments from two biotechs if he is confirmed to lead the U.S. Department of Health and Human Services (HHS). RFK Jr. said he would divest interests in several companies—including CRISPR Therapeutics and Dragonfly Therapeutics—within 90 days, according to a Jan. 21 disclosure letter filed with the Office of Government Ethics. Other companies on the list include Amazon and Apple.
Most of RFK Jr.’s income comes from work as a partner at his law firm, Kennedy & Madonna, which changed its name to Madonna & Madonna on Jan. 13. He brought in about $8.8 million annually from the law firm according the news articles.
Robert F. Kennedy Jr. appears to have changed his mond about vaccines, according to reports.
President Donald Trump’s pick to lead the Department of Health and Human Services is assuring the Republican senators who will decide whether he gets the job that he’s “all for” polio inoculations and that he won’t take away anyone’s vaccines. He has also told them he merely wants to make safety and efficacy data more readily available, lawmakers who’ve talked with Kennedy tell POLITICO. “He told me he is not anti-vaccine. He is pro-vaccine safety, which strikes me as a rational position to take,” said Sen. John Cornyn (R-Texas), who sits on the Finance Committee that will decide whether to send Kennedy’s nomination to the floor
Jeff Newman JD MBA, represents whistleblowers nationwide relating to customs and tariff fraud concerning imported Chinese goods as well as corporate whistleblowers in major claims under the False Claims Act (Qui Tam), and SEC, CFTC and FINCEN whistleblower programs. He can be reached at Jeff@JeffNewmanLaw.com or at 617-823-3217
